159 related articles for article (PubMed ID: 16683063)
1. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
Striano P; Coppola A; Vacca G; Zara F; Brescia Morra V; Orefice G; Striano S
J Neurol; 2006 Jun; 253(6):762-6. PubMed ID: 16683063
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of levetiracetam on upper limb movement in multiple sclerosis patients with cerebellar signs: a multicenter double-blind, placebo-controlled, crossover study.
Solaro C; de Sire A; Messmer Uccelli M; Mueller M; Bergamaschi R; Gasperini C; Restivo DA; Stabile MR; Patti F
Eur J Neurol; 2020 Nov; 27(11):2209-2216. PubMed ID: 32558044
[TBL] [Abstract][Full Text] [Related]
3. Activity, tolerability and efficacy of levetiracetam on cerebellar symptoms in multiple sclerosis patients: a pilot kinematic study.
Solaro C; Brichetto G; Capello E; Abuarqub S; Sanguineti V
Eur J Neurol; 2008 Jun; 15(6):619-26. PubMed ID: 18474077
[TBL] [Abstract][Full Text] [Related]
4. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
Handforth A; Martin FC
Mov Disord; 2004 Oct; 19(10):1215-21. PubMed ID: 15390011
[TBL] [Abstract][Full Text] [Related]
5. An open-label pilot study of levetiracetam for essential tremor.
Ondo WG; Jimenez JE; Vuong KD; Jankovic J
Clin Neuropharmacol; 2004; 27(6):274-7. PubMed ID: 15613931
[TBL] [Abstract][Full Text] [Related]
6. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
7. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study.
Rossi S; Mataluni G; Codecà C; Fiore S; Buttari F; Musella A; Castelli M; Bernardi G; Centonze D
Eur J Neurol; 2009 Mar; 16(3):360-6. PubMed ID: 19364364
[TBL] [Abstract][Full Text] [Related]
8. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
Feys P; D'hooghe MB; Nagels G; Helsen WF
Mult Scler; 2009 Mar; 15(3):371-8. PubMed ID: 19168602
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial.
Glauser TA; Pellock JM; Bebin EM; Fountain NB; Ritter FJ; Jensen CM; Shields WD
Epilepsia; 2002 May; 43(5):518-24. PubMed ID: 12027913
[TBL] [Abstract][Full Text] [Related]
10. Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.
Zesiewicz TA; Sullivan KL; Hauser RA; Sanchez-Ramos J
Mov Disord; 2006 Nov; 21(11):1998-2001. PubMed ID: 16941461
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
Ben-Menachem E; Gilland E
Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group.
Ben-Menachem E; Falter U
Epilepsia; 2000 Oct; 41(10):1276-83. PubMed ID: 11051122
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and safety of levetiracetam in patients with essential tremor: data from an open 11-week follow-up trial].
Sanz-Cartagena P; Fossas P; Floriach-Robert M; Serra-Prat M; Cano A; Palomeras E
Rev Neurol; 2007 Aug 1-15; 45(3):134-6. PubMed ID: 17661270
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam is not effective for essential tremor.
Elble RJ; Lyons KE; Pahwa R
Clin Neuropharmacol; 2007; 30(6):350-6. PubMed ID: 18090460
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of levetiracetam in Huntington disease.
de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis.
Naderi F; Javadi SA; Motamedi M; Sahraian MA
Clin Neuropharmacol; 2012; 35(5):224-6. PubMed ID: 22821064
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study.
Striano P; Manganelli F; Boccella P; Perretti A; Striano S
Mov Disord; 2005 Dec; 20(12):1610-4. PubMed ID: 16078205
[TBL] [Abstract][Full Text] [Related]
18. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia.
Jorns TP; Johnston A; Zakrzewska JM
Eur J Neurol; 2009 Jun; 16(6):740-4. PubMed ID: 19475723
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project).
Consoli D; Bosco D; Postorino P; Galati F; Plastino M; Perticoni GF; Ottonello GA; Passarella B; Ricci S; Neri G; Toni D;
Cerebrovasc Dis; 2012; 34(4):282-9. PubMed ID: 23128439
[TBL] [Abstract][Full Text] [Related]
20. Tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam: A monocenter retrospective outcome analysis.
Hirsch M; Hintz M; Specht A; Schulze-Bonhage A
Seizure; 2018 Oct; 61():98-103. PubMed ID: 30118932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
